An Official Website of the United States Government
Company Information:
Name:
MARKER GENE TECHNOLOGIES, INC
Address:
1850 MILLRACE DRIVE
1850 MILLRACE DRIVE
EUGENE, OR 97403 1992
1850 MILLRACE DRIVE
EUGENE, OR 97403 1992
Located in HUBZone:
Yes
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(541) 342-3760
Award Totals:
Award List:
SBIR Phase I: Marker Gene Directed Substrates for Cell Regulation
Award Year / Program / Phase:
1996 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
John Naleway
Award Amount:
$74,175.00
MARKER GENE DIRECTED SUBSTRATES FOR CELL REGULATION
Award Year / Program / Phase:
1996 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$99,850.00
SBIR Phase I: Marker Gene Directed Substrates for Cell Regulation
Award Year / Program / Phase:
1997 / SBIR / Phase II
Agency:
NSF
Principal Investigator:
John Naleway
Award Amount:
$298,940.00
Genetic Strategies for Drug Targeting
Award Year / Program / Phase:
1998 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Award Amount:
$727,752.00
N/A
Award Year / Program / Phase:
2000 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
John Naleway
Award Amount:
$99,485.00
LIVE CELL APOPTOSIS ASSAY FOR HIGH-THROUGHPUT SCREENING
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Naleway
Award Amount:
$97,406.00
Abstract:
DESCRIPTION (Applicant's Abstract): This Small Business Innovation Research
Phase I project aims to investigate the feasibility of developing new compounds
capable of measuring initial stages of apoptosis induction in living cells and
tissues. If successful, the proposed research… More
SBIR/STTR Phase I: New GUS Substrates for Cell Regulation
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
John Naleway
Award Amount:
$99,972.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project is to develop commercial uses for conjugates capable of exploiting cloned gene expression in transformed plant cells to control their growth and physiology. The specific goal of this project is to synthesize a series of new… More
NEW LABELING REAGENTS FOR GENETIC ANALYSIS
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Naleway
Award Amount:
$99,982.00
Abstract:
DESCRIPTION (provided by applicant): This Small Business Innovation Research
Phase I project aims to investigate the feasibility of developing new,
sensitive, accurate, and reliable detection methods for genomic DNA or RNA
samples that are essential for genomic microarray analysis. If successful,… More
LUCIFERASE DIRECTED SUBSTRATES FOR CELL REGULATION
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Naleway
Award Amount:
$99,850.00
Abstract:
DESCRIPTION (provided by applicant): This Small Business Innovation Research
Phase I project aims to investigate the feasibility of developing new compounds
capable of utilizing common marker gene expression in transformed cells to
control the growth and character of cells in living tissue. If… More
POSITIVE SELECTION SYSTEMS USING MARKER GENES
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Naleway
Award Amount:
$99,879.00
Abstract:
This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new compounds capable of utilizing common marker gene expression in transformed cells to control the growth and character of cells in cell culture and live tissue applications. If successful,… More
Live-Cells Assays for Lysosomal Enzyme Activity
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
John J. Naleway
Award Amount:
$399,644.00
Abstract:
DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in living cells and tissues. If successful, the proposed researc
h will provide breakthroughs needed to… More
SBIR Phase I: New Labeling Reagents for Genetic Analysis
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
John J. Naleway, PhD
Award Amount:
$99,959.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I research project aims to develop novel nucleic acid labeling reagents that can be used in living cells to monitor gene expression. Instead of relying on labeling the molecules using fluorescently labeled bases, the proposed approach relies on… More
SBIR Phase II: New Labeling Reagents for Genetic Analysis
Award Year / Program / Phase:
2009 / SBIR / Phase II
Agency:
NSF
Principal Investigator:
John J. Naleway, PhD
Award Amount:
$499,889.00
Abstract:
This Small Business Innovation Research Phase II project aims to develop new, sensitive, accurate, and reliable detection methods for measuring genomic DNA or RNA samples isolated from living cells. The intellectual merit of this project lies in the development of new detection methods that are… More